Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • The Vagina Monologues: Expanding Reproductive Toxicology to the Vaginal Interface
  • Schedule
    Notes
  • Room 302‚ Convention Center
    Set Timezone


Chair: Kylie Rock, Clemson University

Primary Endorser: Reproductive and Developmental Toxicology Specialty Section


Endorser(s): Women in Toxicology Special Interest Group


Endorser(s): Molecular and Systems Biology Specialty Section


Despite major advances in reproductive toxicology, critical biological interfaces, exposure pathways, and health endpoints within women’s reproductive systems remain insufficiently characterized. Traditional frameworks have largely focused on ovarian function, pregnancy outcomes, and fetal development, while comparatively little attention has been given to the vaginal and cervical microenvironments, dynamic, hormonally responsive systems that serve as primary barriers to external exposures and key regulators of reproductive and gynecologic health. The vaginal epithelium and its associated microbiome are essential for maintaining mucosal integrity, regulating immune responses, and protecting against infection. Disruption of this system has been associated with inflammation, increased susceptibility to sexually transmitted infections, infertility, and preterm birth, highlighting the vaginal interface as a critical yet underrecognized determinant of women’s health across the reproductive lifespan. Importantly, this interface also represents a direct route of exposure to environmental contaminants through feminine hygiene products and personal care items, yet it remains largely absent from current toxicological testing paradigms and risk assessment frameworks. The high permeability of vaginal tissues, coupled with their unique immune and microbial environment, raises important concerns regarding chemical absorption, local toxicity, and systemic health effects that are not captured by traditional exposure models. Addressing these gaps is essential for developing more biologically relevant and protective approaches to chemical safety evaluation.
This session will present an integrated, multi-scale perspective on the vaginal interface as a critical but underappreciated target in toxicology, spanning mechanistic cell biology, exposure science, microbial ecology, engineering approaches, and human epidemiology. The session will open with a trainee-led presentation examining the direct effects of endocrine-disrupting chemicals, specifically phthalates, on vaginal and cervical epithelial cell viability, inflammatory signaling, and barrier integrity, establishing the vaginal epithelium as a biologically active and sensitive target of chemical exposure. The second presentation will examine consumer products as a direct source of exposure, highlighting recent findings demonstrating the presence of metals and PFAS in tampons and their potential to leach under physiologically relevant conditions and be absorbed across highly permeable vaginal tissues. Building on this, the third presentation will explore how vaginal microbes respond to direct phthalate exposure and how these exposures may alter host–microbe interactions within the vaginal microenvironment, promoting inflammation and microbial dysbiosis. Complementary engineering approaches will demonstrate how these systems can be more accurately modeled and targeted through rational drug delivery design, providing innovative strategies to improve therapeutic delivery while minimizing unintended chemical exposures. Finally, the session will conclude with epidemiologic evidence linking variation in the vaginal microbiome to environmental and host factors associated with adverse reproductive outcomes, including preterm birth.
Collectively, this session will address how environmental contaminants directly impact vaginal and cervical epithelial function, how consumer products contribute to localized and systemic exposures through the vaginal route, and how chemical exposures disrupt host–microbe interactions within the vaginal microenvironment to influence inflammation and reproductive health. The session will further highlight emerging engineered models and targeted delivery systems that can improve the study of vaginal toxicology and reduce unintended exposures, while integrating epidemiologic findings that connect environmental exposures, vaginal microbiome alterations, and reproductive outcomes. Together, these presentations position the vaginal interface as a critical and previously underrecognized component of women’s reproductive toxicology. By integrating trainee-led mechanistic research with interdisciplinary and population-level perspectives, this session aims to expand current toxicological frameworks, improve chemical risk evaluation, and catalyze new research directions that more accurately reflect real-world exposure pathways and their implications for women’s health.

Session and Activity Type
Presentations